Ledger.Open graph →
SEC Form D · filed August 11, 2016

INTERLEUKIN GENETICS INC

Offering
$5.6M
Sold
$5.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WATHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Stephen C. Dipalma · Watham, MAExecMark B. Carbeau · Watham, MAExec · DirectorLionel C. Carnot · Watham, MADirectorJoseph M. Landstra · Watham, MADirectorKenneth S. Kornman · Watham, MAExec · DirectorJames C. Weaver · Watham, MADirectorRoger C. Colman · Watham, MADirectorDayton C. Misfeldt · Watham, MADirectorWilliam C. Mills Iii · Watham, MADirectorJoseph M. Landstra · Watham, MADirectorKenneth S. Kornman · Watham, MAExec · DirectorStephen C. Dipalma · Watham, MAExecJames C. Weaver · Watham, MADirectorRoger C. Colman · Watham, MADirectorMark B. Carbeau · Watham, MAExec · DirectorDayton C. Misfeldt · Watham, MADirectorWilliam C. Mills Iii · Watham, MADirectorLionel C. Carnot · Watham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗